Inflammatory mechanisms are increasingly recognized as important contributors to the
pathogenesis of neurodegenerative diseases, including Lewy body dementia (LBD). Our …

Few studies have investigated the role of inflammation in Lewy body dementia (LBD) and
variable results have been found. We systematically reviewed the literature for evidence of …

Background Chronically dysregulated neuroinflammation has been implicated in
neurodegenerative dementias, with separate studies reporting increased brain levels of …

Dementia with Lewy bodies (DLB) is the second most common neurodegenerative cause of
dementia, behind Alzheimer's disease (AD). The profile of inflammation in AD has been …

Objectives There is growing evidence for the role of systemic inflammation in Alzheimer's
disease (AD) and other neurodegenerative diseases; however the systemic inflammatory …

Evidence is accumulating that the pathogenesis of Alzheimer disease (AD) and other
neurodegenerative conditions involves mechanisms that operate outside the brain, and new …

Background Inflammation plays a key role in the aetiology and progression of Alzheimer's
disease (AD). However, the immunophenotype of the second most common …

Neuroinflammation is increasingly recognized as a key factor in the pathogenesis of
neurodegenerative conditions. However, it remains unclear whether it has a protective or …

Dementia with Lewy bodies (DLB) is characterized by alpha-synuclein protein deposition
with variable degree of concurrent Alzheimer's pathology. Neuroinflammation is also …

Inflammation is increasingly recognized as part of the pathology of neurodegenerative
conditions such as Alzheimer's disease and Parkinson's disease, but its role in dementia …